Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: Eyeing Nash, Glympse Raises $22M To Test Disease Detection Nanotech
Venture Capital

Xconomy: Eyeing Nash, Glympse Raises $22M To Test Disease Detection Nanotech

by xconomy.com posted 2months ago 31 views
Glympse Bio has developed sensor technology that it says can give clinicians an early look at a developing disease. As Glympse prepares to test its disease detection approach in a serious liver disorder, the startup has raised $22 million in Series A financing. LS Polaris Innovation Fund and Arch Venture Partners co-led the investment in Cambridge, […]

In this article